028300.KQ

HLB Co., Ltd. [028300.KQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

028300.KQ Stock Summary

Top 10 Correlated Stocks

028300.KQ

In the News

028300.KQ Financial details

Company Rating
-
Market Cap
12142.95B
Income
-189.08B
Revenue
42.9B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
133
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-49.38
Forward P/E
-
PEG
-4.42
P/S
76.31
P/B
9.24
P/C
-
P/FCF
-74.13
Quick Ratio
1.55
Current Ratio
1.65
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.47K
EPS next Y
-
EPS next Q
-
EPS this Y
124.66%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
28.9%
Revenue last 5Y
2.23%
Revenue Q/Q
-7.28%
EPS Q/Q
458.18%
-
-
-
-
SMA20
-0.56%
SMA50
-21.57%
SMA100
-9.1%
Inst Own
-
Inst Trans
-
ROA
-13%
ROE
-20%
ROC
-0.15%
Gross Margin
18%
Oper. Margin
-145%
Profit Margin
-146%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
27550.0-129000.0
52W High
-71.63%
52W Low
+32.85%
RSI
34
Rel Volume
0.09
Avg Volume
3.8M
Volume
332.31K
Perf Week
-27.09%
Perf Month
-27.52%
Perf Quarter
-29.62%
Perf Half Y
-21.37%
-
-
-
-
Beta
0.481
-
-
Volatility
4879.67%, 3146.81%
Prev Close
-29.89%
Price
36600
Change
-27.67%

Something similar

Top by Market Cap
JPM
AAPL
LLY
FB2A.DE
0YXG.L
Same Sector
PCYN
6819.HK
CBAY
CVET
QUIA.ST
Top Correlated Stocks
003580.KS
067630.KQ
KRPZ.L
Similar Market Cap
032830.KS
047050.KS
7267.T
PWON.JK
000810.KS

Company Profile

Healthcare Biotechnology
  • Volume Average 3.8M
  • Market Capitalization 12142.95B
  • Employee 133
  • CEO Mr. Jung-Min Park
  • Headquarters Ulsan,KR
  • IPO Date 2008-12-24
  • Website https://www.hlbkorea.com

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats and davits. In addition, the company develops Riboseranib, a targeted anti-cancer agent; and Apilia that is used for the treatment for ovarian cancer. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.